KATHLEEN PALMER: Open Payments
NPI 1174932347 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 69 payments from 12 companies in 2025. Trend: 2023 $1,522 · 2024 $896 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $283 |
| GlaxoSmithKline, LLC. | 16 | $238 |
| Novo Nordisk Inc | 14 | $187 |
| SANOFI-AVENTIS U.S. LLC | 3 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Lilly USA, LLC | 3 | $50 |
| Corcept Therapeutics | 3 | $48 |
| PFIZER INC. | 2 | $34 |
| IBSA Pharma Inc. | 2 | $32 |
| Medtronic, Inc. | 1 | $22 |
Products named: VRAYLAR, SHINGRIX, TZIELD, MOUNJARO, Korlym, Rybelsus, TRELEGY ELLIPTA, QULIPTA.
Industry payments across NJ — which companies pay providers there.
